|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, February 22, 2017 ) According to Publisher, the Myocardial Infarction Therapeutics Market is estimated at $XX million in 2015 and is projected to reach $XX million by 2022 growing at a CAGR of XX% from 2015 to 2022. Growing research application, rising demand in increasing incidence of coronary artery disease and changes in lifestyle are some of the key factors driving the market growth. Increasing number of smokers, increasing incidence of obesity and blood pressures, lack of exercise are some of the factors favouring the market growth. However, saturation in R&D would be the major restraint hampering the market.
For more information about this report: http://www.reportsweb.com/myocardial-infarction-therapeutics-global-market-outlook-2015-2022
Analgesics and antiplatelet agents segments are expected to hold more share in this market as these agents are used for initial treatment of an acute myocardial infarction. North America is the fastest growing market in global myocardial infarction therapeutic market due to rise in aging population and prevalence of co-morbidities.
Some of the key players in the market include Anthera Pharmaceuticals, AstraZeneca, Apotex Inc., Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Capricor Inc., Daiichi Sankyo Company Limited, GlaxoSmithKline Plc, Johnson & Johnson, Merck and Co. Inc., Mylan N.V., Novartis N.V., Par Pharmaceutical Companies, Inc., Pfizer Inc., Portola Pharmaceuticals Inc., Sandoz, Sanofi and The Medicines Company.
Products Covered:
- Analgesics
- Antiplatelet agents
- Vasodilators
- Thrombolytics and anti-thrombotic agents
- Glycoprotein IIb/IIIa inhibitors
- Î’ adrenergic blockers
- Angiotensin receptor antagonists
- Angiotensin converting enzyme inhibitors
- Antithrombotic agents
Distribution Channel Covered:
- Hospitals
- Hospital Pharmacies
- Drug Stores
- Online drug stores
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001216391/sample
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- Rest of Asia Pacific
- Rest of the World
- Middle East
- Brazil
- Argentina
- South Africa
- Egypt
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Company Profiling
9.1 Anthera Pharmaceuticals
9.2 AstraZeneca, Apotex Inc.
9.3 Bayer AG
9.4 Boehringer Ingelheim GmbH
9.5 Bristol-Myers Squibb Company
9.6 Capricor Inc.
9.7 Daiichi Sankyo Company Limited
9.8 GlaxoSmithKline Plc
9.9 Johnson & Johnson
9.10 Merck and Co. Inc.
9.11 Mylan N.V.
9.12 Novartis N.V.
9.13 Par Pharmaceutical Companies, Inc.
9.14 Pfizer Inc.
9.15 Portola Pharmaceuticals Inc.
9.16 Sandoz
9.17 Sanofi
9.18 The Medicines Company
Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001216391/buying
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
